About the SPORE
The Mayo Clinic Ovarian Cancer SPORE supports research to improve the diagnosis and treatment of ovarian cancer, fallopian tube cancer and primary peritoneal cancer and to better understand susceptibility to these cancers.
The SPORE includes four major translational research projects, the Developmental Research Program and the Career Enhancement Program. The Ovarian Cancer SPORE is part of the Women's Cancer Program, a formal research program within the Mayo Clinic Cancer Center.
The Ovarian Cancer SPORE uses an interdisciplinary approach to meet its objectives for research on ovarian cancer and related cancers. Co-investigators in the SPORE's research projects have expertise in basic research, population science and clinical investigation.
SPORE investigators work together as a team to meet the goals of the SPORE and also interact with investigators from SPOREs and ovarian cancer research groups at other institutions to improve therapeutic outcomes for patients.
The Mayo Clinic Ovarian Cancer SPORE is funded by the National Cancer Institute (NCI), which awarded Mayo Clinic a five-year, $11.2 million grant in September 2015. A SPORE, or Specialized Program of Research Excellence, is the cornerstone of the NCI's efforts to promote collaborative, interdisciplinary translational research.
The principal investigator for the Mayo Clinic Ovarian Cancer SPORE is: